Bafna Pharmaceuticals gains on launching new products Afenac, Nocaf, Izabof in domestic market

25 Nov 2013 Evaluate

Bafna Pharmaceuticals is currently trading at Rs. 32.25, up by 3.00 points or 9.92% from its previous closing of Rs. 30.25 on the BSE.

The scrip opened at Rs. 30.90 and has touched a high and low of Rs. 33.90 and Rs. 30.40 respectively. So far 40,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 51.70 on 07-Jan-2013 and a 52 week low of Rs. 17.90 on 29-Jul-2013.

Last one week high and low of the scrip stood at Rs. 33.00 and Rs. 25.05 respectively. The current market cap of the company is Rs. 62 crore.

The promoters holding in the company stood at 30.87% while Non-Institutions held 69.13%.

Bafna Pharmaceuticals, a Chennai-based Pharma company, has launched Afenac-P Tablets, Afenac TH Tablets, Nocaf Syrup, Izabof Suspension, Izabof-250 86 500 mg Tablets in domestic market. By launching these new products, the company has expanded its base into Pain Management & Anti-infectives.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.

Bafna Pharma Share Price

88.00 -0.44 (-0.50%)
24-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.35
Dr. Reddys Lab 5962.50
Cipla 1400.00
Zydus Lifesciences 933.40
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.